Announced plans for new, state-of-the-art ... second line. This underscores the transformational benefits of this therapy and the importance of our efforts to expand patient access,” said Ying Huang, ...

As one of the premier global events for the biotechnology, pharmaceutical ... bioreagents, and state-of-the-art equipment, focusing on how these innovations reshape research. Tsingke's presence ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of ...

To build out the facility and ensure the success of this new venture, QPS has hired Tia Hexom, PhD, (Senior Director of Cell ...

Transgene, ProBioGen join forces to advance individualized cancer vaccine development: Strasbourg, France Thursday, November 7, 2024, 11:00 Hrs [IST] Transgene, a biotech company ...

The earnings season is in its final week; giants of nifty and sensex have already posted their Q2 results. Today, their 1181 ...

Q3 2024 Earnings Call Transcript November 4, 2024 Revvity, Inc. misses on earnings expectations. Reported EPS is $0.935 EPS, ...

In addition, Origin Agritech's breakthrough gene editing technology, including the world's first efficient genetic transformation system for maize induction line Hi3 ... China Golden Marker ...

Immunocore reports third quarter financial results and provides a business updateKIMMTRAK® (tebentafusp-tebn) net revenues of $80.2 million in 3Q ...

BEIJING, Oct. 21, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce the establishment ...